|
OvUtCa_Mayo Clinic |
Ovarian/Uterine Cancer (OvUtCa) |
Mayo Clinic |
Case, Control |
|
|
|
|
|
Demonstration Project T2D Implementation |
Type 2 Diabetes - Demonstration Project |
Vanderbilt University |
Case, Control |
|
|
100%, 100% |
|
|
Marshfield Implementation Version 5 |
Pneumonia- VUMC eMERGE v5.1 |
Marshfield Clinic Research Institute |
Case Only |
|
|
|
|
|
CHOP SLE Implementation |
SLE (Systemic Lupus Erythematosus) using SLICC (Systemic Lupus Internation Collaborating Clinics) Criteria |
CHOP |
Case, Control |
|
|
|
|
|
Marshfield NAFLD Implementation |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
|
Case Only |
|
|
|
|
|
Appendicitis Case 2-MED |
Appendicitis |
Cincinnati Children's Hospital Medical Center |
Case Only |
|
|
90% |
|
|
Cataracts Vanderbilt Implementation |
Cataracts |
Vanderbilt University |
Case Only |
|
|
96% |
|
|
CHOP anxiety |
Anxiety algorithm |
CHOP |
Case, Control |
|
|
|
|
|
AFH Implementation Columbia (updated) |
Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia |
Columbia University |
Case, Control |
|
|
|
|
|
CHOP Part I |
Epilepsy/Antiepileptic drug response algorithm |
CHOP |
Case, Control |
|
|
92% |
|
|
Validation of Asthma algorithm - Marshfield |
Asthma |
Marshfield Clinic |
Case, Control |
|
|
96%, 96% |
|
|
Hypothyroidism GHC Implementation |
Hypothyroidism |
Group Health Cooperative |
Case, Control |
|
|
98%, 100% |
|
|
Mount Sinai -- T2DM |
Type 2 Diabetes - PRS Evaluation |
Mount Sinai |
Case Only |
|
|
|
|
|
Marshfield CRC Implementation |
Colorectal Cancer (CRC) |
Marshfield Clinic Research Institute |
Case Only |
|
|
|
|
|
Severe Early Childhood Obesity - Vanderbilt |
Severe Early Childhood Obesity |
Vanderbilt |
Case, Control |
|
|
99%, 98% |
|
|
WBC Marshfield Implementation |
White Blood Cell Indices |
Marshfield Clinic Research Foundation |
Case Only |
|
|
90% |
88% |
|
Atopic dermatitis implementation - Marshfield |
Atopic Dermatitis Algorithm |
Marshfield Clinic Research Foundation |
Case, Control |
|
|
96%, 90% |
|
|
Demonstration Project RA Implementation |
Rheumatoid Arthritis - Demonstration Project |
Vanderbilt University |
Case, Control |
|
|
97%, 100% |
|
|
Pneumonia_data_4_7_institutes |
Pneumonia- VUMC eMERGE v5.1 |
|
Case Only |
|
|
|
|
|
Geisinger eMERGE3 Combined Implementation |
Diverticulosis and Diverticulitis |
Geisinger |
Case, Control |
|
|
97%, 94% |
|
|
Columbia Lupus Implementation |
SLE (Systemic Lupus Erythematosus) using SLICC (Systemic Lupus Internation Collaborating Clinics) Criteria |
Columbia University Medical Center |
Case, Control |
|
|
|
|
|
NAFLD_Mayo clinic implementation |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
Mayo Clinic |
Case, Control |
|
|
|
|
|
CHOP implementation Case 1 and Controls |
Appendicitis |
CHOP |
Case, Control |
|
|
86%, 100% |
|
|
Mayo implementation |
Cardiorespiratory Fitness Algorithm (eMERGE Mayo Network Phenotype) |
Mayo Clinic |
Case Only |
|
|
|
|
|
Cataracts-Columbia |
Cataracts |
Columbia University |
Case Only |
|
|
|
|
